What does a BUP urine drug screen test for?

Table of Contents

1. Introduction
2. What Does a BUP Urine Drug Screen Test For?
3. Hysen Company Solutions
4. References

Introduction

The BUP urine drug screen is an essential tool in clinical and forensic settings to detect the presence of buprenorphine. Buprenorphine is a semi-synthetic opioid used primarily in the treatment of opioid addiction and pain management. Understanding the scope and capability of a BUP urine drug screen is vital for healthcare professionals and patients alike.

What Does a BUP Urine Drug Screen Test For?

A BUP urine drug screen is designed specifically to detect buprenorphine and its metabolites in urine samples. Buprenorphine is metabolized in the liver, producing metabolites such as norbuprenorphine. The detection of these substances is crucial for ensuring adherence to prescribed treatment regimens or abstinence from illicit drug use.

Parameters and Detection Levels

The standard detection threshold for buprenorphine is typically set at 5-10 ng/mL. Laboratories can measure concentrations depending on the sensitivity of their equipment and their specific testing protocols. The urine drug screen can confirm buprenorphine usage within 3-6 days after the last dose. This range can vary based on factors such as the individual's metabolism, hydration levels, and the dosage taken.

Specific Numerical Analysis

• Detection Limit: 5-10 ng/mL
• Window of Detection: 3-6 days post-administration
• Common Metabolites Detected: Buprenorphine, Norbuprenorphine

Hysen Company Solutions

Hysen Company provides innovative drug testing solutions for healthcare facilities, rehabilitation centers, and workplaces. Their state-of-the-art BUP urine drug screen kits offer high accuracy and reliability, ensuring efficient monitoring of buprenorphine use.

Advantages of Hysen's BUP Test Kits

1. High Sensitivity: Detects as low as 5 ng/mL, ensuring even minimal usage is identified.
2. Rapid Results: Provides test results within 5-10 minutes, allowing for quick decision-making.
3. Cost-Effective: Offers competitive pricing to maximize accessibility for all users.
4. Compliance with Standards: Meets regulatory guidelines for accuracy and reliability.

References

• Substance Abuse and Mental Health Services Administration. Clinical Drug Testing in Primary Care. HHS Publication No. (SMA) 12-4668.
• National Institute on Drug Abuse. Commonly Used Drug Tests. National Institutes of Health.
• Hysen Company. BUP Test Kits Product Specifications. Hysen Pharmaceuticals.